These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 22109647

  • 1. Pharmacological genome demethylation increases radiosensitivity of head and neck squamous carcinoma cells.
    Brieger J, Mann SA, Pongsapich W, Koutsimpelas D, Fruth K, Mann WJ.
    Int J Mol Med; 2012 Mar; 29(3):505-9. PubMed ID: 22109647
    [Abstract] [Full Text] [Related]

  • 2. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D, Pongsapich W, Heinrich U, Mann S, Mann WJ, Brieger J.
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [Abstract] [Full Text] [Related]

  • 3. Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma.
    Brieger J, Pongsapich W, Mann SA, Hedrich J, Fruth K, Pogozelski B, Mann WJ.
    Oral Oncol; 2010 Sep; 46(9):678-83. PubMed ID: 20729134
    [Abstract] [Full Text] [Related]

  • 4. MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinoma.
    Pattani KM, Soudry E, Glazer CA, Ochs MF, Wang H, Schussel J, Sun W, Hennessey P, Mydlarz W, Loyo M, Demokan S, Smith IM, Califano JA.
    PLoS One; 2012 Sep; 7(9):e45534. PubMed ID: 23029077
    [Abstract] [Full Text] [Related]

  • 5. Radioresistance in a human laryngeal squamous cell carcinoma cell line is associated with DNA methylation changes and topoisomerase II α.
    Kim JS, Kim SY, Lee M, Kim SH, Kim SM, Kim EJ.
    Cancer Biol Ther; 2015 Sep; 16(4):558-66. PubMed ID: 25719218
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
    Chaisaingmongkol J, Popanda O, Warta R, Dyckhoff G, Herpel E, Geiselhart L, Claus R, Lasitschka F, Campos B, Oakes CC, Bermejo JL, Herold-Mende C, Plass C, Schmezer P.
    Oncogene; 2012 Dec 06; 31(49):5108-16. PubMed ID: 22286769
    [Abstract] [Full Text] [Related]

  • 8. Demethylation Therapy as a Targeted Treatment for Human Papillomavirus-Associated Head and Neck Cancer.
    Biktasova A, Hajek M, Sewell A, Gary C, Bellinger G, Deshpande HA, Bhatia A, Burtness B, Judson B, Mehra S, Yarbrough WG, Issaeva N.
    Clin Cancer Res; 2017 Dec 01; 23(23):7276-7287. PubMed ID: 28916527
    [Abstract] [Full Text] [Related]

  • 9. 5-aza-2'-Deoxycytidine enhances the radiosensitivity of breast cancer cells.
    Wang L, Zhang Y, Li R, Chen Y, Pan X, Li G, Dai F, Yang J.
    Cancer Biother Radiopharm; 2013 Feb 01; 28(1):34-44. PubMed ID: 22917213
    [Abstract] [Full Text] [Related]

  • 10. Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors.
    Chen X, Liu L, Mims J, Punska EC, Williams KE, Zhao W, Arcaro KF, Tsang AW, Zhou X, Furdui CM.
    Epigenetics; 2015 Feb 01; 10(6):545-61. PubMed ID: 25961636
    [Abstract] [Full Text] [Related]

  • 11. Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
    Misawa Y, Misawa K, Kanazawa T, Uehara T, Endo S, Mochizuki D, Yamatodani T, Carey TE, Mineta H.
    Cancer; 2014 Jan 15; 120(2):205-13. PubMed ID: 24122450
    [Abstract] [Full Text] [Related]

  • 12. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
    Meng CF, Dai DQ, Guo KJ.
    Ai Zheng; 2008 Dec 15; 27(12):1251-5. PubMed ID: 19079988
    [Abstract] [Full Text] [Related]

  • 13. The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas.
    Nakayama S, Sasaki A, Mese H, Alcalde RE, Tsuji T, Matsumura T.
    Int J Cancer; 2001 Sep 01; 93(5):667-73. PubMed ID: 11477576
    [Abstract] [Full Text] [Related]

  • 14. A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma.
    De Schutter H, Kimpe M, Isebaert S, Nuyts S.
    Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):904-12. PubMed ID: 19215824
    [Abstract] [Full Text] [Related]

  • 15. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation.
    Dong SW, Cui YT, Zhong RR, Liang DC, Liu YM, Wang YG, He Z, Wang S, Liang SJ, Zhang P.
    Clin Lab; 2012 Mar 01; 58(1-2):41-51. PubMed ID: 22372344
    [Abstract] [Full Text] [Related]

  • 16. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells.
    Bai T, Tanaka T, Yukawa K, Umesaki N.
    Int J Oncol; 2006 Feb 01; 28(2):497-508. PubMed ID: 16391806
    [Abstract] [Full Text] [Related]

  • 17. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
    Reu FJ, Bae SI, Cherkassky L, Leaman DW, Lindner D, Beaulieu N, MacLeod AR, Borden EC.
    J Clin Oncol; 2006 Aug 10; 24(23):3771-9. PubMed ID: 16801630
    [Abstract] [Full Text] [Related]

  • 18. Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma.
    Huang C, Zhou X, Li Z, Liu H, He Y, Ye G, Huang K.
    Mol Med Rep; 2016 Sep 10; 14(3):2489-96. PubMed ID: 27485791
    [Abstract] [Full Text] [Related]

  • 19. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ, Zhang S, Guo C, Zhang S, Wang Y, Zhang D.
    Laryngoscope; 2005 Aug 10; 115(8):1395-401. PubMed ID: 16094112
    [Abstract] [Full Text] [Related]

  • 20. Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation.
    Coombes MM, Briggs KL, Bone JR, Clayman GL, El-Naggar AK, Dent SY.
    Oncogene; 2003 Dec 04; 22(55):8902-11. PubMed ID: 14654786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.